Data Insights
                                    By  Company Name
                                
                                No Filter Selected
                                    By  Disease Name
                                
                                No Filter Selected
                                    By  Drug Name
                                
                                No Filter Selected
                                    By Themes
                                
                                No Filter Selected
                                    Showing 1 results out of 1                                
                                
                                                Data Insights
                                                
                                        YNK-105 by Yinuoke for Cancer Anorexia-Cachexia Syndrome: Likelihood of Approval
YNK-105 is under clinical development by Yinuoke and currently in Phase I for Cancer Anorexia-Cachexia Syndrome. According to GlobalData, Phase...
